Acurx Pharmaceuticals, INC. (ACXP) — S-1 Filings

S-1 Filings (5)

• Acurx Files S-1 for Lincoln Park Resale, Eyes $9M More in Funding — Oct 20, 2025 Risk: high
  Acurx Pharmaceuticals, Inc. (ACXP) filed an S-1 to register an additional 585,000 shares of common stock for resale by Lincoln Park Capital Fund, LLC, stemming
• Acurx Pharma Files S-1 for Public Offering, Eyes Capital Raise — Jul 15, 2025 Risk: high
  Acurx Pharmaceuticals, Inc. (ACXP) filed an S-1 registration statement on July 15, 2025, for a proposed public offering of securities, indicating its intent to
• Acurx Pharmaceuticals Files S-1 Registration — May 21, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. filed an S-1 registration statement with the SEC on May 21, 2025. The company, incorporated in Delaware, is seeking to register secu
• Acurx Pharmaceuticals Files S-1 Registration — Apr 4, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. filed an S-1 registration statement on April 4, 2025, to register securities under the Securities Act of 1933. The company, incorpor
• Acurx Pharmaceuticals Files S-1 — Jan 31, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. filed an S-1 form on January 31, 2025, detailing its business operations and financial status. The company, incorporated in Delaware

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX